Chronic fatigue syndrome

Evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue

Barry Hurwitz, Kimberly A. Brownley, Maryann Fletcher, Nancy G. Klimas

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Chronic Fatigue Syndrome (CFS) is a disorder characterized by a prolonged, debilitating fatigue of unknown etiology. In addition, patients with CFS frequently report enhanced fatigue symptoms following even mild physical exertion, and their tolerance for physical exercise is limited relative to healthy individuals. The physiological mechanisms underlying the excessive fatigue and weakness common to this disorder remain an issue of scientific debate. Collectively, the available data suggest that fatigue in CFS is not due to any neuromuscular dysfunction, per se, but possibly is caused or influenced by some centrally acting mediator that is released during behavioral activities that require physical or mental exertion. In addition to persistent fatigue, there is growing evidence that many CFS patients exhibit alterations in hypothalamic-pituitary-adrenal (HPA) axis and autonomic function, including the inability to maintain the blood pressure response to orthostatic challenge. When an individual engages in mental or physical behavioral activation, there is a release of numerous centrally acting neuromodulators, some of which have been postulated to influence fatigue. This paper examines the evidence supporting a common pathway through which these centrally-mediated psychological and autonomic abnormalities may be linked. It is hypothesized that as a consequence of behavioral activation there is an abnormality in neuromodulator release or action in individuals with CFS, and that this abnormal neuromodulator activity results in increased fatigue. Furthermore, it is postulated that the CNS initiates a counter-regulatory mechanism to reduce the activity of those systems responsible for the production of the neuromodulator; and that the consequence of this counter-regulatory maneuver is the prevailing dysregulation of the autonomic and HPA axes and other dysfunctional cardiovascular and immunological sequelae.

Original languageEnglish
Pages (from-to)45-63
Number of pages19
JournalJournal of Chronic Fatigue Syndrome
Volume6
Issue number2
StatePublished - Sep 11 2000

Fingerprint

Chronic Fatigue Syndrome
Fatigue
Neurotransmitter Agents
Exercise
Physical Exertion
Psychology
Blood Pressure

Keywords

  • Adrenal
  • Autonomic
  • Cardiovascular
  • Chronic fatigue syndrome
  • Cytokine
  • Immune
  • Neuromodulator

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Chronic fatigue syndrome : Evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue. / Hurwitz, Barry; Brownley, Kimberly A.; Fletcher, Maryann; Klimas, Nancy G.

In: Journal of Chronic Fatigue Syndrome, Vol. 6, No. 2, 11.09.2000, p. 45-63.

Research output: Contribution to journalArticle

@article{f920db555e5d42c38c222b2bab914929,
title = "Chronic fatigue syndrome: Evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue",
abstract = "Chronic Fatigue Syndrome (CFS) is a disorder characterized by a prolonged, debilitating fatigue of unknown etiology. In addition, patients with CFS frequently report enhanced fatigue symptoms following even mild physical exertion, and their tolerance for physical exercise is limited relative to healthy individuals. The physiological mechanisms underlying the excessive fatigue and weakness common to this disorder remain an issue of scientific debate. Collectively, the available data suggest that fatigue in CFS is not due to any neuromuscular dysfunction, per se, but possibly is caused or influenced by some centrally acting mediator that is released during behavioral activities that require physical or mental exertion. In addition to persistent fatigue, there is growing evidence that many CFS patients exhibit alterations in hypothalamic-pituitary-adrenal (HPA) axis and autonomic function, including the inability to maintain the blood pressure response to orthostatic challenge. When an individual engages in mental or physical behavioral activation, there is a release of numerous centrally acting neuromodulators, some of which have been postulated to influence fatigue. This paper examines the evidence supporting a common pathway through which these centrally-mediated psychological and autonomic abnormalities may be linked. It is hypothesized that as a consequence of behavioral activation there is an abnormality in neuromodulator release or action in individuals with CFS, and that this abnormal neuromodulator activity results in increased fatigue. Furthermore, it is postulated that the CNS initiates a counter-regulatory mechanism to reduce the activity of those systems responsible for the production of the neuromodulator; and that the consequence of this counter-regulatory maneuver is the prevailing dysregulation of the autonomic and HPA axes and other dysfunctional cardiovascular and immunological sequelae.",
keywords = "Adrenal, Autonomic, Cardiovascular, Chronic fatigue syndrome, Cytokine, Immune, Neuromodulator",
author = "Barry Hurwitz and Brownley, {Kimberly A.} and Maryann Fletcher and Klimas, {Nancy G.}",
year = "2000",
month = "9",
day = "11",
language = "English",
volume = "6",
pages = "45--63",
journal = "Journal of Chronic Fatigue Syndrome",
issn = "1057-3321",
publisher = "The Haworth Medical Press",
number = "2",

}

TY - JOUR

T1 - Chronic fatigue syndrome

T2 - Evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue

AU - Hurwitz, Barry

AU - Brownley, Kimberly A.

AU - Fletcher, Maryann

AU - Klimas, Nancy G.

PY - 2000/9/11

Y1 - 2000/9/11

N2 - Chronic Fatigue Syndrome (CFS) is a disorder characterized by a prolonged, debilitating fatigue of unknown etiology. In addition, patients with CFS frequently report enhanced fatigue symptoms following even mild physical exertion, and their tolerance for physical exercise is limited relative to healthy individuals. The physiological mechanisms underlying the excessive fatigue and weakness common to this disorder remain an issue of scientific debate. Collectively, the available data suggest that fatigue in CFS is not due to any neuromuscular dysfunction, per se, but possibly is caused or influenced by some centrally acting mediator that is released during behavioral activities that require physical or mental exertion. In addition to persistent fatigue, there is growing evidence that many CFS patients exhibit alterations in hypothalamic-pituitary-adrenal (HPA) axis and autonomic function, including the inability to maintain the blood pressure response to orthostatic challenge. When an individual engages in mental or physical behavioral activation, there is a release of numerous centrally acting neuromodulators, some of which have been postulated to influence fatigue. This paper examines the evidence supporting a common pathway through which these centrally-mediated psychological and autonomic abnormalities may be linked. It is hypothesized that as a consequence of behavioral activation there is an abnormality in neuromodulator release or action in individuals with CFS, and that this abnormal neuromodulator activity results in increased fatigue. Furthermore, it is postulated that the CNS initiates a counter-regulatory mechanism to reduce the activity of those systems responsible for the production of the neuromodulator; and that the consequence of this counter-regulatory maneuver is the prevailing dysregulation of the autonomic and HPA axes and other dysfunctional cardiovascular and immunological sequelae.

AB - Chronic Fatigue Syndrome (CFS) is a disorder characterized by a prolonged, debilitating fatigue of unknown etiology. In addition, patients with CFS frequently report enhanced fatigue symptoms following even mild physical exertion, and their tolerance for physical exercise is limited relative to healthy individuals. The physiological mechanisms underlying the excessive fatigue and weakness common to this disorder remain an issue of scientific debate. Collectively, the available data suggest that fatigue in CFS is not due to any neuromuscular dysfunction, per se, but possibly is caused or influenced by some centrally acting mediator that is released during behavioral activities that require physical or mental exertion. In addition to persistent fatigue, there is growing evidence that many CFS patients exhibit alterations in hypothalamic-pituitary-adrenal (HPA) axis and autonomic function, including the inability to maintain the blood pressure response to orthostatic challenge. When an individual engages in mental or physical behavioral activation, there is a release of numerous centrally acting neuromodulators, some of which have been postulated to influence fatigue. This paper examines the evidence supporting a common pathway through which these centrally-mediated psychological and autonomic abnormalities may be linked. It is hypothesized that as a consequence of behavioral activation there is an abnormality in neuromodulator release or action in individuals with CFS, and that this abnormal neuromodulator activity results in increased fatigue. Furthermore, it is postulated that the CNS initiates a counter-regulatory mechanism to reduce the activity of those systems responsible for the production of the neuromodulator; and that the consequence of this counter-regulatory maneuver is the prevailing dysregulation of the autonomic and HPA axes and other dysfunctional cardiovascular and immunological sequelae.

KW - Adrenal

KW - Autonomic

KW - Cardiovascular

KW - Chronic fatigue syndrome

KW - Cytokine

KW - Immune

KW - Neuromodulator

UR - http://www.scopus.com/inward/record.url?scp=0033849014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033849014&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 45

EP - 63

JO - Journal of Chronic Fatigue Syndrome

JF - Journal of Chronic Fatigue Syndrome

SN - 1057-3321

IS - 2

ER -